title: Antidepressant use: concordance between self-report and claims records.
abstract: BACKGROUND
  Researchers need valid methods to assess whether patients are taking their antidepressant medications. Two important sources of data on drug exposure are patients' self-reports and pharmacy claims.
  
  
  OBJECTIVE
  To compare self-report and claims data for antidepressant exposure.
  
  
  METHODS
  Cross-sectional analysis.
  
  
  METHODS
  This study comprised 422 contemporaneous self-report and claims data points obtained from 164 unique patients in a longitudinal depression study in which patients completed up to five surveys during an 18-month period.
  
  
  METHODS
  For the self-report measure, the following question was asked: Do you now take any prescription medicines for depression? Using claims data, patients were considered to be using an antidepressant if they had filled at least one antidepressant prescription in the 90 days before survey dates.
  
  
  RESULTS
  Self-report and claims agreed in 85% (358/422) of cases, with a kappa of 0.69. Eighty-eight percent (56/64) of discrepant cases using other study data sources was resolved. Reasons for discrepancies included the use of medications for conditions other than depression (32/64), recent AD discontinuations (6/64), samples usage (3/64), and low-frequency/PRN use (7/64).
  
  
  CONCLUSIONS
  Self-report and claims showed good concordance, but they reflect different truths. Self-report identifies medications intended primarily for the treatment of depressive disorders, whereas claims data identify use of medicines with antidepressant effects. Our assessment of discordant cases showed self-report to be more valid than claims to assess current antidepressant use for depression therapy.
authors.affiliation: Health Institute, Division of Clinical Care Research, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA.
authors.forename: Anne
authors.initials: A
authors.lastname: Kwon
authors.forename: Kathleen M
authors.initials: KM
authors.lastname: Bungay
authors.forename: Yu
authors.initials: Y
authors.lastname: Pei
authors.forename: William H
authors.initials: WH
authors.lastname: Rogers
authors.forename: Ira B
authors.initials: IB
authors.lastname: Wilson
authors.forename: Qi
authors.initials: Q
authors.lastname: Zhou
authors.forename: David A
authors.initials: DA
authors.lastname: Adler
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001900:Boston; D003430:Cross-Sectional Studies; D003865:Major Depressive Disorder / Q000188:drug therapy*; D019263:Dysthymic Disorder / Q000188:drug therapy*; D006279:Health Maintenance Organizations; D006302:Health Services Research; D006801:Humans; D007345:Insurance Claim Review; D007356:Insurance, Pharmaceutical Services / Q000706:statistics & numerical data*; D008137:Longitudinal Studies; D008875:Middle Aged; D010349:Patient Compliance / Q000706:statistics & numerical data*; D015203:Reproducibility of Results; D012650:Self Disclosure; D011795:Surveys and Questionnaires
chemical_list: D000928:Antidepressive Agents